Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Lu

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 16, 2013
VCP gene variation predicts outcome of advanced non-small-cell lung cancer platinum-based chemotherapyJ Peng, L X Yang, X Y Zhao, et al.
Lung Cancer (Amsterdam, Netherlands)|March 21, 2013
XBP1 promoter polymorphism modulates platinum-based chemotherapy gastrointestinal toxicity for advanced non-small cell lung cancer patientsJ Peng, Y Y Chen, L X Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2018
Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trialH S Rugo, V Diéras, K A Gelmon, et al.
ESMO Open|January 4, 2025
Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109)E Agostinetto, G Pfeiler, D Hlauschek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2016
Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized studyS Faivre, P Niccoli, D Castellano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
Palbociclib with adjuvant endocrine therapy in early breast cancer: 5-year follow-up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13)E L Mayer, D Hlauschek, M Gnant, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 16, 2013
VCP gene variation predicts outcome of advanced non-small-cell lung cancer platinum-based chemotherapyJ Peng, L X Yang, X Y Zhao, et al.
Lung Cancer (Amsterdam, Netherlands)|March 21, 2013
XBP1 promoter polymorphism modulates platinum-based chemotherapy gastrointestinal toxicity for advanced non-small cell lung cancer patientsJ Peng, Y Y Chen, L X Yang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2018
Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trialH S Rugo, V Diéras, K A Gelmon, et al.
ESMO Open|January 4, 2025
Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109)E Agostinetto, G Pfeiler, D Hlauschek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2016
Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized studyS Faivre, P Niccoli, D Castellano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
Palbociclib with adjuvant endocrine therapy in early breast cancer: 5-year follow-up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13)E L Mayer, D Hlauschek, M Gnant, et al.
Pageof 5